Gabapentin long term effects
Pro Research Analysisby 
Searched over 200M research papers
Long-Term Effects of Gabapentin: A Comprehensive Review
Gabapentin and Postherpetic Neuralgia: Safety and Weight Gain
Gabapentin, particularly in its gastroretentive formulation (G-GR), has been studied for long-term safety and tolerability in patients with postherpetic neuralgia (PHN). A study involving an extension of a 10-week double-blind trial to an additional 14 weeks found that the incidence of common adverse events (AEs) such as dizziness and somnolence remained low, and the severity of these AEs did not increase with prolonged use. Weight gain was minimal, with an average increase of less than 1 kg over the 24-week period, and only 2.5% of patients reported weight gain as an adverse event .
Gabapentin in Postoperative Pain Management
Gabapentin has shown efficacy in reducing postoperative pain and opioid consumption. A systematic review of randomized controlled trials indicated that gabapentin significantly reduced opioid-related adverse effects such as nausea, vomiting, and urinary retention. However, common side effects included sedation and dizziness. The review highlighted the need for further studies to determine the optimal dose and duration for long-term benefits .
Long-Term Use in Spinal Cord Injury Pain
In patients with traumatic spinal cord injury, gabapentin has been effective in managing pain over a long-term period. A longitudinal study with follow-ups at 6 and 36 months found that a significant proportion of patients continued to report pain relief without developing tolerance to the drug. Common side effects included sedation, dizziness, and forgetfulness, but these did not lead to discontinuation in most cases .
Effects on Cognitive and Behavioral Outcomes
Gabapentin's long-term effects on cognitive and behavioral outcomes have been studied in animal models. Chronic treatment following status epilepticus reduced spontaneous seizure frequency and cell damage without adverse effects on learning, memory, or behavior. This suggests that gabapentin does not negatively impact cognitive processes during development .
Gabapentin and Restless Legs Syndrome
Gabapentin has been used to treat restless legs syndrome (RLS), but its efficacy may be reduced in patients previously treated with dopaminergic agents. A study found that long-term dopaminergic treatment dampened the response to gabapentin enacarbil, indicating that initial treatment choices in RLS should be carefully considered .
Impact on Sleep and Respiratory Function
Gabapentin may acutely worsen sleep breathing in older adults. A study found that a bedtime dose of gabapentin increased the apnea-hypopnea index and oxygen desaturation index in non-obese older men, suggesting potential risks for sleep-related breathing disorders with long-term use .
Pediatric Use and Emergence Delirium
In pediatric patients undergoing tonsillectomy and adenoidectomy, gabapentin has been investigated for its potential to reduce emergence delirium (ED). While no statistical significance was found, there was a clinically significant reduction in ED behaviors, warranting further research into its benefits in pediatric postoperative care .
Conclusion
Gabapentin is generally well-tolerated for long-term use in various conditions, including postherpetic neuralgia, spinal cord injury pain, and postoperative pain management. However, its side effects, such as sedation and dizziness, and potential impacts on sleep breathing and response in RLS patients previously treated with dopaminergic agents, highlight the need for careful patient selection and monitoring. Further research is necessary to fully understand the long-term benefits and risks of gabapentin across different patient populations.
Sources and full results
Most relevant research papers on this topic